Plasma Ascorbic acid, total cholesterol, High density lipoprotein cholesterol levels and Total cholesterol/High density lipoprotein cholesterol ratio were determined in 52 newly diagnosed hypercholesterolaemic subjects and 48 normocholesterolaemic subjects. Hypercholesterolaemic subjects were defined as those with plasma total cholesterol ≥200mg/dl. The results showed that the mean plasma ascorbic acid levels were significantly lower in hypercholesterolaemic subjects when compared to normocholesterolaemics (P< 0.005) while total cholesterol , high density lipoprotein cholesterol and total cholesterol/high density lipoprotein cholesterol ratio were higher in hypercholesterolaemics than control (P<0.005). The low ascorbic acid levels observed in hypercholesterolaemics may be due to increased lipid peroxidation and hence low ascorbic acid levels may play a role in the aetiology of hypercholesterolaemia and therefore vitamin C supplements maybe useful in the management of Hypercholesterolaemia.
INTRODUCTION
Plasma lipids have many physiological functions and they have been incriminated as aetiological factors in atherosclerosis and coronary heart disease 1 . Hypercholesterolaemia is due to an increase in both free and esterified cholesterol. It could be genetic, acquired or may be secondary to other disorders or to dietary factors 2 .
The beneficial effect of lowering serum cholesterol have been demonstrated in several experiments and results show that reducing serum cholesterol on average by just 1 mmol/l (34.6 mg/dl) with diet or drugs resulted in significant decreases in the incidence of coronary heart disease and rate of progression of coronary lesions 3 .
Ascorbic acid has antioxidant properties protecting cellular membranes 4 and could therefore protect against atherosclerosis 5 ; of which hypercholesterolaemia is a risk factor. This study is aimed at determining the level of ascorbic acid in hypercholesterolaemics.
MATERIALS AND METHODS

SUBJECTS AND SAMPLES
Patients attending the medical outpatient of the University of Benin Teaching Hospital, Benin City, Nigeria, had their plasma total and high density lipoprotein cholesterol estimated and those with total cholesterol levels ≥ 200 mg/dl were selected for the study as hypercholesterolaemic subjects. 52 newly diagnosed subjects were selected for this study and 48 apparently healthy normocholesterolaemic subjects were used as control. Prior to the study, the subjects were not on Ascorbic acid supplement and were also not on treatment as they had no knowledge of their cholesterol levels.
10 ml of venous blood sample were collected in appropriately labeled potassium EDTA anticoagulated containers. These were centrifuged and plasma separated into appropriately labeled containers. The cholesterol was assayed immediately while the plasma was stored frozen and the Ascorbic acid assayed within 48 hours. 
ESTIMATION OF PLASMA ASCORBIC ACID
REAGENTS
METHOD OF ANALYSIS
The 2, 4-dinitrophenylhydrazine method by Roe and kuether as modified by Daphne was used in estimating plasma ascorbic acid 6 
PRINCIPLE
Ascorbic acid is oxidized to dehydroascorbate by the action of 2,6-dichlorophenolindophenol. The dehydrate is hydrolysed to diketogulonic acid in the strongly acid medium. This forms an Osazone with 2, 4 dinitrophenyl hydrazine. The Osazone rearranges to a stable reddish brown product which can be measured photometrically at 500 nm. PROCEDURE 2 ml plasma was pipetted into centrifuge tube. 6 ml of 5% TCA was added and mixed thoroughly. This was centrifuged and the protein free supernatant was used for the estimation. 2 ml of supernatant were pipetted into tubes marked 'sample' and 'sample blank'.
2 ml ascorbic acid standard was pipetted into tubes marked 'standard' and 2 ml of 5%TCA into a tube marked standard blank.
0.1 ml of indophenol was added to all tubes and mixed thoroughly. 0.5 ml Dinitrophenylhydrazine-Thiourea reagent was added to the standard and samples. All tubes were incubated for 1 hour in a 60°C water bath.0.5 ml DinitrophenylhydrazineThiourea reagent was added to standard blank and all sample blanks. While all the tubes remain in ice water, 2.5 ml 85% sulfuric acid was added to all tubes and mixed thoroughly. The absorbance of were read at 500 nm using a spectrophotometer. 
CALCULATION
PROCEDURE
To 1000ul of reagent in tubes meant for samples, standard and blank, 10µl of samples, standard and distilled water were added respectively. The content was mixed and incubated for 5mins at 37°C. The absorbance of the samples and standard was measured against reagent blank at 546nm 
PRINCIPLE
Low density lipoproteins (LDL and VLDL) and chylomicron fractions are precipitated quantitatively by the addition of acid phosphotungstic in the presence of magnesium ions. After centrifugation the cholesterol concentration in the HDL (high density lipoprotein) fraction, which remains in the supernatant is determined.
PROCEDURE
Into centrifuged tubes, 500µl of sample and 100µl of HDLcholesterol precipitant was added, mixed and allowed to stand for 10mins at room temperature .The tubes were centrifuged at 4,000rpm.100µl of supernatant were assayed for cholesterol estimation with the procedure given above for total cholesterol estimation. 
STATISTICAL ANALYSIS
All measures of central tendencies and dispersion were analyzed using descriptive statistics in statistical packages for social sciences (SPSS) statistical package. The nonparametric Kruskal-Wallis test was used to test for the significant difference.
RESULTS
The results showed that there was a significant decrease in the plasma ascorbic acid level of hypercholesterolaemic subjects. The total cholesterol, HDL-cholesterol and Total cholesterol / HDL-cholesterol ratio increased significantly when compared with control. (P<0.05) TC/HDL-C ratio is the most effective lipid profile for predicting coronary heart disease. Progression of growth of coronary lesion is associated with relatively high values for TC/HDL-C ratio while low values have no disease progression. 8 . The hypothesis that elevated plasma cholesterol may induce endothelial dysfunction and thus contribute to atherosclerosis has been a particular focus of attention. It has been demonstrated that lipid peroxidation products are damaging to the cells and can initiate a sequence of events leading to atherosclerotic lesion 9 .
Ascorbic acid is an antioxidant, protecting cellular membrane thus preventing oxidative stress and damage 10 . It reduces lipid peroxidation thus preventing the development of atherosclerotic plaques. Therefore the findings of elevated total cholesterol levels and low levels of plasma ascorbic acid in hypercholesterolaemic subjects is an indication of predisposition to risk of developing atherosclerosis. Ascorbic acid deficiency leads to defective formation of intracellular substances. The low levels as observed in the hypercholesterolaemic subjects can amplify tissue damage caused by lipid peroxidation thereby resulting in the development of atherosclerosis.
CONCLUSION
We conclude that hypercholesterolaemics have lower levels of plasma ascorbic acid compared with normocholesterolaemics. This low level of Ascorbic acid may not be dietary but may be due to the increased demand for ascorbic acid due to high lipid peroxidation in hypercholesterolaemics, Ascorbic acid supplements may be beneficial in the management of hypercholesterolaemia.
